IBDEI2KY ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41178,1,3,0)
 ;;=3^DM Type 1 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,41178,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,41178,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,41179,0)
 ;;=E10.22^^152^2029^3
 ;;^UTILITY(U,$J,358.3,41179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41179,1,3,0)
 ;;=3^DM Type 1 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,41179,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,41179,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,41180,0)
 ;;=E10.29^^152^2029^24
 ;;^UTILITY(U,$J,358.3,41180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41180,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,41180,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,41180,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,41181,0)
 ;;=E10.311^^152^2029^12
 ;;^UTILITY(U,$J,358.3,41181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41181,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,41181,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,41181,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,41182,0)
 ;;=E10.319^^152^2029^13
 ;;^UTILITY(U,$J,358.3,41182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41182,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,41182,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,41182,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,41183,0)
 ;;=E10.3211^^152^2029^19
 ;;^UTILITY(U,$J,358.3,41183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41183,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,41183,1,4,0)
 ;;=4^E10.3211
 ;;^UTILITY(U,$J,358.3,41183,2)
 ;;=^5138279
 ;;^UTILITY(U,$J,358.3,41184,0)
 ;;=E10.3212^^152^2029^20
 ;;^UTILITY(U,$J,358.3,41184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41184,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,41184,1,4,0)
 ;;=4^E10.3212
 ;;^UTILITY(U,$J,358.3,41184,2)
 ;;=^5138280
 ;;^UTILITY(U,$J,358.3,41185,0)
 ;;=E10.3213^^152^2029^21
 ;;^UTILITY(U,$J,358.3,41185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41185,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,41185,1,4,0)
 ;;=4^E10.3213
 ;;^UTILITY(U,$J,358.3,41185,2)
 ;;=^5138281
 ;;^UTILITY(U,$J,358.3,41186,0)
 ;;=E10.39^^152^2029^26
 ;;^UTILITY(U,$J,358.3,41186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41186,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,41186,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,41186,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,41187,0)
 ;;=E10.40^^152^2029^10
 ;;^UTILITY(U,$J,358.3,41187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41187,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,41187,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,41187,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,41188,0)
 ;;=E10.41^^152^2029^7
 ;;^UTILITY(U,$J,358.3,41188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41188,1,3,0)
 ;;=3^DM Type 1 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,41188,1,4,0)
 ;;=4^E10.41
 ;;^UTILITY(U,$J,358.3,41188,2)
 ;;=^5002605
 ;;^UTILITY(U,$J,358.3,41189,0)
 ;;=E10.42^^152^2029^11
 ;;^UTILITY(U,$J,358.3,41189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41189,1,3,0)
 ;;=3^DM Type 1 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,41189,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,41189,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,41190,0)
 ;;=E10.43^^152^2029^2
